Phase
Condition
Dermatitis, Atopic
Allergy
Hives (Urticaria)
Treatment
N/AClinical Study ID
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
patients aged 18-60 y.o. diagnosed with atopic dermatitis according to the UKrefinement of the Hanifin-Rajka diagnostic criteria;
SCORAD Index more than 25.
Exclusion
Exclusion Criteria:
pregnancy and breast-feeding;
severe diseases;
concomitant infection diseases (including parasitic ones);
diffusive connective-tissue (autoimmune) diseases;
renal and hepatic failure;
systemic or topical treatment with antibiotics, steroids, immunosuppressive,cytostatic or antimetabolite agents by the time of inclusion into the study;
concomitant skin diseases: skin lymphoma, scab, lichen ruber planus, psoriasis;
professional activity involving skin injury, exposure to cold, insolation, ultravioletradiation;
psychoses;
application of pre-, probiotics, antibiotics, neuroleptics or tranquilizers 2 weeksbefore inclusion or during participation in the study;
participation in other clinical study 1 month before inclusion or during participationin the proposed study.
Study Design
Connect with a study center
Moscow Dermatovenerologic Clinical Dispensary № 1
Moscow, 119071
Russian FederationSite Not Available
Moscow State University of Medicine and Dentistry
Moscow, 127473
Russian FederationSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.